Previous studies have reported the frequency of altered IKZF1 in AML to range between 1.2% in a pediatric cohort of 258 patients [36] and 2.6% to 4.8% in three adult cohorts including 193, 475, and 522 patients, respectively [37–39]. The gene discussed is IKZF1; the disease is acute myeloid leukemia.